Evaluation of risk for development of myeloproliferative disorders, myelodysplastic syndromes, or acute leukemias with long-term eculizumab therapy in paroxysmal nocturnal hemoglobinuria (PNH) patients

被引：0
|
作者：
Schubert, J.
Young, N. S.
Luzzatto, L.
Brodsky, R. A.
Socie, G.
Rother, R. P.
Rollins, S. A.
Hillmen, P.
机构：
[1] Saarland Univ, Sch Med, Homburg, Germany
[2] NHLBI, Bethesda, MD 20892 USA
[3] Ist Toscano Tumori, Florence, Italy
[4] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[5] Hosp St Louis, Paris, France
[6] INSERM, Paris, France
[7] Alexion Pharmaceut Inc, Cheshire, CT USA
[8] Leeds Gen Infirm, Leeds, W Yorkshire, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7087
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Chronic Renal Insufficiency in Japanese Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Improvement with Eculizumab Treatment in the Long-Term Follow-up of the AEGIS Study
    Kanakura, Yuzuru
    Ohyashiki, Kazuma
    Shichishima, Tsutomu
    Okamoto, Shinichiro
    Ando, Kiyoshi
    Ninomiya, Haruhiko
    Kawaguchi, Tatsuya
    Nakao, Shinji
    Nakakuma, Hideki
    Nishimura, Jun-ichi
    Kinoshita, Taroh
    Bedrosian, Camille
    Valentine, Marye Ellen
    Ozawa, Keiya
    Omine, Mitsuhiro
    BLOOD, 2009, 114 (22) : 783 - 784
  • [22] Long term stability of red cell responses in patients with paroxysmal nocturnal haemoglobinuria (PNH) on eculizumab therapy: implications for the future treatment and management of PNH
    Richards, SJ
    Cullen, MJ
    Dickinson, AJ
    Hill, A
    Buchanon, D
    Arnold, L
    Elebute, M
    Rother, RP
    Hillmen, P
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 16 - 16
  • [23] Diagnosis of an indolent malignant Nnon-Hodgkin lymphoma (NHL) in a patient with paroxysmal nocturnal hemoglobinuria (PNH) under long-term treatment with Eculizumab
    Bistritan, C. I.
    Theodoropoulou, S.
    Aul, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 258 - 258
  • [24] Improvement of Renal Function by Long-Term Sustained Eculizumab Treatment in a Patient with Paroxysmal Nocturnal Hemoglobinuria
    Ninomiya, Haruhiko
    Obara, Naoshi
    Niiori-Onishi, Akiko
    Yokoyama, Yasuhisa
    Sakata-Yanagimoto, Mamiko
    Hasegawa, Yuichi
    Chiba, Shigeru
    CASE REPORTS IN HEMATOLOGY, 2015, 2015
  • [25] Long-term Survival Benefit of Eculizumab Treatment in Patients With Paroxysmal Nocturnal Haemoglobinuria: Data From the International PNH Registry
    Griffin, Morag
    Terriou, Louis
    Patriquin, Christopher J.
    Lee, Jong Wook
    Gustovic, Philippe
    Patel, Ami S.
    Szer, Jeff
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 8 - 9
  • [26] Paroxysmal nocturnal hemoglobinuria (PNH): Long term follow up of 48 patients in a single institution.
    Ruiz, Jefferson
    Medeiros, Larissa A.
    Funke, Vaneuza A. M.
    Bonfim, Carmem M. S.
    Bitencourt, Marco A.
    Setubal, Daniela C.
    Pettengil, Claudia
    Nunes, Elenaide C.
    Oliveira, Michel M.
    Neto, Jose Zanis
    Medeiros, Carlos R.
    Malvezzi, Mariester
    Pasquini, Ricardo
    BLOOD, 2006, 108 (11) : 14B - 14B
  • [27] Benefits and Limitations of Long-Term Eculizumab Treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH): Real-World Data from Large Cohort Study in Russia
    Kulagin, Aleksandr
    Klimova, Olesya
    Rudakova, Tatiana
    Golubovskaya, Irina
    Ivanova, Maria
    Smirnova, Anna
    Lapina, Alexandra
    Bykova, Tatiana
    Babenko, Elena
    Popova, Marina
    Dobronravov, Vladimir
    Afanasyev, Boris
    BLOOD, 2018, 132
  • [28] A Case with Paroxysmal Nocturnal Hemoglobinuria with Long-term Remission Due to Immunosuppressive Therapy
    Doi, Takehiko
    Kawaguchi, Hiroshi
    Mizoguchi, Yoko
    Nishimura, Shiho
    Karakawa, Shuhei
    Okada, Satoshi
    Kobayashi, Masao
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S111 - S111
  • [29] Long standing eculizumab treatment without anticoagulant therapy in high-risk thrombogenic paroxysmal nocturnal hemoglobinuria
    Al-Jafar, Hassan A.
    AlDallal, Salma M.
    Askar, Haifa A.
    Aljeraiwi, Ali M.
    Al-Alansari, Ahmad
    HEMATOLOGY REPORTS, 2015, 7 (03) : 63 - 65
  • [30] Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan
    Ikezoe, Takayuki
    Noji, Hideyoshi
    Ueda, Yasutaka
    Kanda, Yoshinobu
    Okamoto, Shinichiro
    Usuki, Kensuke
    Matsuda, Takahisa
    Akiyama, Hirozumi
    Shimono, Akihiko
    Yonemura, Yuji
    Kawaguchi, Tatsuya
    Chiba, Shigeru
    Kanakura, Yuzuru
    Nishimura, Jun-Ichi
    Ninomiya, Haruhiko
    Obara, Naoshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (04) : 470 - 480
12345